Latest in Dermatology

Dermatology at a glance

The 10 latest articles on Dermatology come from 9 sources, published between Oct 29 and Nov 13. Most come from Stock Titan (2).

People in these stories: Heather Buschman (2), George Y. Liu (2), Liu (2), Stacey L. Kolar (2), Juan Torres (2), Chih-Ming Tsai (2)

Organizations: FDA (3), Arcutis Biotherapeutics (2), Cedars-Sinai (2), UCLA (2), Division of Pediatric Infectious Diseases (2), UC San Diego School of Medicine (2)

Places: U.S. (3), United States (2), MD (2), UC (2), San Diego (2)

stocktitan.net
1,569 words

Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting

Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive)How Sentiment works Sentiment and the balance of points Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with…

620 words

Russian cancer vaccine developer announces tumor success

Home#newsRussian cancer vaccine developer announces tumor success #news Published on 13.11.2026 By Russophile Official FacebookTwitterPinterestWhatsApp A melanoma patient’s metastases have disappeared, according to the Gamaleya Research Institute The first patient treated with Russia’s personalized cancer vaccine has recorded no new…

marketscreener.com
440 words

Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes Due to Kras and Mek Inhibitors

Published on 10/29/2026 at 08:30 am EDT Azitra, Inc. announced amendments to its ongoing Phase 1/2 clinical trial of ATR04-484 that significantly expand patient eligibility to include individuals with rash associated with KRAS and MEK inhibitors. The expanded eligibility also includes patients with neurofibromatosis…